[1]
“Incretin Mimetics and DPP-4 Inhibitors: New Approach to Treatment of Type 2 Diabetes Mellitus”, Mymensingh Med. J., vol. 18, no. 1, pp. 113–124, Feb. 2009, doi: 10.3329/mmj.v18i1.2101.